SCHEMBL18894575

SCHEMBL18894575

CC(=O)C1CCC=CC1C#N

nearest known ligand 0.46

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.46
CHRNB2 P17787 1/20 0.31
CHRNA3 P32297 1/20 0.31
CHRNA4 P43681 1/20 0.31
CHRNB3 Q05901 1/20 0.31
CHRNA6 Q15825 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22819234 0.73 MAPT (0.42) MAPT
SCHEMBL18165594 0.72 MAPT (0.51) MAPT
SCHEMBL18165570 0.72 MAPT (0.51) MAPT
SCHEMBL18165565 0.72 MAPT (0.51) MAPT
SCHEMBL1783386 0.72 MAPT (0.56) MAPT
SCHEMBL18165567 0.72 MAPT (0.51) MAPT
SCHEMBL17085339 0.72 MAPT (0.51) MAPT
SCHEMBL26550965 0.70 MAPT (0.50) MAPT
SCHEMBL18736437 0.70
SCHEMBL12927382 0.69 MAPT (0.49) MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3380471-A1 COMT INHIBITING METHODS AND COMPOSITIONS Lieber Institute For Brain Development (US) 2018-10-03 EP disclosed
WO-2017091818-A1 COMT INHIBITING METHODS AND COMPOSITIONS LIEBER INSTITUTE FOR BRAIN DEVELOPMENT (US) 2017-06-01 WO disclosed